• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Cumulative number of Civil Money Penalties filed for the FY against Tobacco Retailers (excluding internet based)

Dictionary: The Family Smoking Prevention and Tobacco Control Act amended the Federal Food, Drug, and Cosmetic Act and provided the FDA with a broad set of sanctions for violations of the law. Such sanctions may include: warning letter, civil money penalty, import alert, seizure, injunction, and criminal prosecution.

Civil Money Penalties are assessed against tobacco product retailers not in compliance with tobacco product requirements. For more information about the agency’s current policies with respect to civil money penalties for retailers who are in violation, please see CTP’s website Guidance, Compliance & Regulatory Information, to find the guidance entitled, “Guidance for FDA and Tobacco Retailers Civil Money Penalties and No-Tobacco-Sale Orders For Tobacco Retailers.”

Information is current as of May 30, 2014

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A0
Nov 2011N/A1
Dec 2011N/A8
Jan 2012N/A29
Feb 2012N/A61
Mar 2012N/A102
Apr 2012N/A147
May 2012N/A177
Jun 2012N/A245
Jul 2012N/A323
Aug 2012N/A385
Sep 2012N/A385

FY 2012 Cumulative Total: 385

Number of Civil Money Penalties filed in the month against Tobacco Retailers (excluding internet based)

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A0
Nov 2011N/A1
Dec 2011N/A7
Jan 2012N/A21
Feb 2012N/A32
Mar 2012N/A41
Apr 2012N/A45
May 2012N/A30
Jun 2012N/A68
Jul 2012N/A78
Aug 2012N/A62
Sep 2012N/A0

FY 2012 Total: 385

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.